Cited by 85Ovarian function and disordersEndometriosis Research and TreatmentReproductive Biology and Fertility

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

Palomba, Stefano, Russo, Tiziana, Orio, Francesco, Falbo, Angela, Manguso, Francesco, Cascella, Teresa, Tolino, Achille, Carmina, Enrico +2 more·2006·Human Reproduction

Abstract

BACKGROUND: Metformin has been shown to improve fertility in anovulatory patients with polycystic ovary syndrome (PCOS), inducing not only a high ovulation and pregnancy rate but also reducing the incidence of miscarriages. The aim of the present study was to evaluate the uterine effects of metformin in patients with PCOS who ovulated under metformin. METHODS: Thirty-seven non-obese primary infertile anovulatory patients with PCOS and another 30 age- and body mass index-matched healthy women (control group) were studied. PCOS patients were treated with metformin (850 mg twice daily) for 6 months, whereas the control group did not receive any treatment. In these PCOS patients who ovulated whilst under metformin treatment (PCOS group) and in controls, uterine, sub-endometrial and endometrial blood flow, and endometrial thickness and pattern were evaluated using serial ultrasonographic assessments. RESULTS: Before treatment, uterine, sub-endometrial and endometrial blood flows were significantly lower in patients with PCOS than in the control group. All indexes of uterine vascularization were significantly improved in the PCOS group with metformin treatment and were not different from the controls. Nor was any difference in endometrial thickness and pattern detected between PCOS and control groups. After grouping the data of PCOS patients who ovulated under metformin for cycles with favourable/unfavourable reproductive outcome, no difference in any parameter was observed. CONCLUSIONS: Metformin improves all surrogate markers of endometrial receptivity in PCOS patients, without difference between patients who had favourable or unfavourable reproductive outcome.

Integrity signals

Registry

Crossref · 10.1093/humrep/dei351

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment with metformin improves markers of endometrial receptivity in women with PCOS, including increased uterine blood flow.

    “Treatment with metformin, a drug prescribed for diabetes as well as PCOS, improves markers of endometrial receptivity in women with PCOS, including increased uterine blood flow (Palomba et al., 2006).”

    From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Palomba et al., 2006

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Palomba, S., Russo, T., Orio, F., Falbo, A., Manguso, F., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F.
Affiliations
  • Magna Graecia University (IT)
  • University of Naples Federico II (IT)
  • Federico II University Hospital (IT)
Corresponding author
Palomba, Stefano
Venue
Human Reproduction
Published
2005-10-27
Volume
21
Issue
2
Pages
457-465
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2134509388
Cited by
85
References
68
Citations by year
2026: 1 · 2025: 5 · 2024: 2 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 7 · 2013: 5 · 2012: 3
FWCI
7.66
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
metformin, polycystic ovary syndrome, anovulatory infertility, uterine blood flow, endometrial blood flow, endometrial thickness, endometrial receptivity, ovulation induction, reproductive outcomes
MeSH terms
Adult, Anovulation, Endometrium, Female, Fertility Agents, Humans, Menstruation-Inducing Agents, Metformin, Polycystic Ovary Syndrome, Regional Blood Flow, Uterus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review